Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Vera Therapeutics, Inc. (VERA) had Weighted-Average Shares Outstanding (Diluted) of 71.48M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-121.03M |
|
-- |
|
-- |
|
$125.13M |
|
$-125.13M |
|
$4.10M |
|
$-121.03M |
|
$-121.03M |
|
$-121.03M |
|
$-121.03M |
|
$-121.03M |
|
$-121.03M |
|
$-125.13M |
|
$-125.20M |
|
71.48M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
71.48M |
$-1.69 |
|
$-1.69 |
|
| Balance Sheet Financials | |
$615.80M |
|
-- |
|
$5.94M |
|
$621.74M |
|
$45.15M |
|
$75.03M |
|
$76.89M |
|
$122.04M |
|
$499.70M |
|
$499.70M |
|
$499.70M |
|
71.73M |
|
| Cash Flow Statement Financials | |
$-106.50M |
|
$-137.82M |
|
$3.94M |
|
$354.73M |
|
$114.35M |
|
$-240.37M |
|
$13.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.64 |
|
-- |
|
-- |
|
0.13 |
|
0.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-106.52M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.22% |
|
-24.22% |
|
-19.47% |
|
-21.06% |
|
$6.97 |
|
$-1.49 |
|
$-1.49 |
|